© 2020 MJH Life Sciences and AJMC. All rights reserved.
© 2020 AJMC. All rights reserved.
Even though dupilumab was a late entrant to the market to treat asthma, its efficacy “speaks for itself."
Defining the economic burden and the pathophysiology of type 2 inflammation in asthma.
Findings from a new study do not support the use of vitamin D supplementation to prevent severe asthma exacerbations in children with persistent asthma.
Patients who have oral corticosteroid–dependent asthma are recommended to use dupilumab, which reduces the use of oral steroids.